KV-1131
KV-1131 IC50 0.93 microM AChE; IC50 1.17 microM MAO-B
General
Type : Monoamine-oxidase-inhibitor, Multitarget, Quinazoline, Sulfur Compound, Morpholine
Chemical_Nomenclature : 4-(4-Phenyl-8-(prop-2-yn-1-yloxy)-5,6-dihydrobenzo[h]quinazolin-2-yl)thiomorpholine
Canonical SMILES : C1=CC=CC=C1C2=NC(=NC3=C2CCC4=C3C=CC(=C4)OCC#C)N5CCSCC53
InChI : 3InChI=1S\/C25H23N3OS\/c1-2-14-29-20-9-11-21-19(17-20)8-10-22-23(18-6-4-3-5-7-18)26-25(27-24(21)22)28-12-15-30-16-13-28\/h1,3-7,9,11,17H,8,10,12-16H23
InChIKey : 3UNWBLFKAPOTJRN-UHFFFAOYSA-N
Other name(s) :
Target
Families : KV-1131 ligand of proteins in family
ACHE
Protein :
human-ACHE
References (1)
| Title : ML-based prediction to experimental validation: Development of dihydroquinazoline based multi-potent ligands as anti-Alzheimer's agents - Jangid_2025_Comput.Biol.Med_196_110762 |
| Author(s) : Jangid K , Devi B , Kumar N , Upadhayay S , Kumar V , Thareja S |
| Ref : Computers in Biology & Medicine , 196 :110762 , 2025 |
| Abstract : |
| PubMedSearch : Jangid_2025_Comput.Biol.Med_196_110762 |
| PubMedID: 40664126 |